2h
Hosted on MSNHALO's Q4 Earnings Beat, Higher Royalties Drive Revenue GrowthHalozyme Therapeutics HALO reported fourth-quarter 2024 adjusted earnings of $1.26 per share, which beat the Zacks Consensus ...
Q4 2024 Earnings Call Transcript February 18, 2025 Halozyme Therapeutics, Inc. beats earnings expectations. Reported EPS is ...
Will Ferrell explains why we never got an Elf 2. It's no secret that Hollywood really loves sequels. There is a lot of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results